QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Local therapy combined with chemotherapy versus chemotherapy for postoperative oligometastatic non-small-cell lung cancer 期刊论文 FUTURE ONCOLOGY, 2019, 卷号: 15, 期号: 14, 页码: 1593-1603 作者:  Shang, Shuheng;  Wang, Linlin;  Su, Yi;  Li, Butuo;  Guo, Meiying 收藏  |  浏览/下载：19/0  |  提交时间：2019/12/11 chemotherapy  local ablative therapy  non-small-cell lung cancer  oligometastases  postoperation   BIM Deletion Polymorphism Confers Resistance to Osimertinib in EGFR T790M Lung Cancer: a Case Report and Literature Review 期刊论文 TARGETED ONCOLOGY, 2018, 卷号: 13, 期号: 4, 页码: 517-523 作者:  Li, Xuanzong;  Wang, Shijiang;  Li, Butuo;  Wang, Zhen;  Shang, Shuheng 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11 Local ablative therapy with or without chemotherapy for non-small-cell lung cancer patients with postoperative oligometastases 期刊论文 CANCER MANAGEMENT AND RESEARCH, 2018, 卷号: 10, 页码: 6421-6429 作者:  Shang, Shuheng;  Su, Yi;  Zhu, Zhaofeng;  Li, Butuo;  Guo, Meiying 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11 postoperation  oligometastases  non-small-cell lung cancer  local  ablative therapy  chemotherapy   Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC 期刊论文 ONCOTARGETS AND THERAPY, 2018, 卷号: 11, 页码: 6287-6294 作者:  Li, Butuo;  Li, Cheng;  Guo, Meiying;  Shang, Shuheng;  Li, Xiaogang 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/11 lactate dehydrogenase  bevacizumab  non-small-cell lung cancer  mixed-effect model  predictive factor